Jia-Ao Yu

Jia-Ao Yu

Auto-generated profile, based on publicly available information

Jia-Ao Yu

Department of Burns, The First Hospital of Jilin University, Changchun, 130021, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JZJing-Chun Zhao
Jing-Chun Zhao
BZBo-Ru Zhang
Bo-Ru Zhang
KSKai Shi
Kai Shi
XZXi Zhang
Xi Zhang
CXChun-Hui Xie
Chun-Hui Xie
JYJia-Ao Yu
Jia-Ao Yu
To investigate the clinical characteristics and treatment outcomes in necrotizing fasciitis (NF) patients in a reconstructive unit in northeastern China. Medical records of patients diagnosed with and treated for NF in the extremities from November 2013 to December 2016 were retrospectively reviewed. Demographic data, clinical presentation, duration of signs and symptoms, location of infection, predisposing factors, causative microbiological organisms, laboratory risk indicator for necrotizing fasciitis (LRINEC) score, number of surgical debridements, length of hospital stay, treatments, and outcomes were recorded. A total of 39 consecutive patients were treated for severe NF (32 male and 7 female). Diabetes mellitus and blunt trauma were the most common risk factors (13 and 9 cases, respectively). The positive predictive value of the LRINEC score in NF diagnosis was 46.2%. Mean duration of signs and symptoms was 4.6 days. Staphylococcus aureus was the most commonly isolated bacteria (20 cases). All patients underwent their first debridement within 12 h of presentation (mean, 4.6 h). Mean number of surgical treatments was 2.8 (range, 2–5) per patient, including debridements. All patients survived, and mean length of hospital stay was 30.81 (range, 21–43) days. Three patients underwent limb amputation. In our clinical experience, early detection and aggressive debridement are the cornerstones of NF treatment. Antibiotic therapy and intensive care support is essential in severe cases of NF. Anaerobic tissue culture and frozen section biopsy could be adopted as routine tests for diagnosis and decision-making in NF. These findings should inform clinical decisions about the treatment of individual patients with NF.

1 May 2020 in Journal of Tissue Viability
Verified
Journal Article
Closed access
JZJing-Chun Zhao
Jing-Chun Zhao
XFXing Fan
Xing Fan
JYJia-Ao Yu
Jia-Ao Yu
Xiu-Hang ZhangXiu-Hang Zhang
Xiu-Hang Zhang
KSKai Shi
Kai Shi
LHLei Hong
Lei Hong

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JZJing-Chun Zhao
Jing-Chun Zhao
Xiu-Hang ZhangXiu-Hang Zhang
Xiu-Hang Zhang
NZNan Zhang
Nan Zhang
ZWZhen-Dong Wu
Zhen-Dong Wu
JWJian Wang
Jian Wang
JYJia-Ao Yu
Jia-Ao Yu
Background. Although the incidence and mortality of complicated skin and soft tissue infections have decreased, this infection is still relatively frequent and can be associated with lethal complications. In this study, the authors present our clinical experience of patients with complicated posterior cervical skin and soft tissue infections (CPCSSTIs) diagnosed and treated in a reconstructive unit in northeastern China. Methods. A retrospective chart review of patients diagnosed with CPCSSTIs from January 2009 to December 2018 was performed. To make the results objective and convincing, a data analysis was performed relating to demographic characteristics, clinical presentation, predisposing factor, bacterial culture, laboratory and radiographic evaluations, diagnostic clues, management, and complications as well as the clinical course and outcome. Results. During the ten‐year period, there were 174 consecutive patients admitted to our reconstructive center with final diagnosis of CPCSSTIs included. All the patients were adults, and the majority were male (67.2%). The patient’s mean age was 51.3 years (range, 15‐88 years). There were 114 patients (65.5%) that had associated systemic diseases, with diabetes mellitus (40.2%) as the most common predisposing factor. Common presented clinical symptoms were pain (90.8%), swelling (85.1%), and erythema (77%) of the neck. Surgical treatment was performed in all the patients, and most of them (83.9%) received the first surgery within 24 h. The most commonly isolated pathogen was Staphylococcus aureus (30%). Vancomycin (21.3%) was the most commonly used antibiotics, followed by cefepime (18.4%). All the patients survived and were discharged with a mean duration of hospitalization of 28.7 days. Those patients with predisposing factors (31.4 ± 12.35 days) or complications (41.0 ± 12.5 days) tended to have a longer hospital stay. The mean total costs of admission per patient were 47 644 RMB. Conclusion. This study highlights the high cost burden of CPCSSTI patients. Those patients with predisposing factors or complications tended to have a longer hospital stay.

3 March 2020 in Journal of Burn Care & Research
Verified
Journal Article
Closed access
PDF file
XCXinxin Chen
Xinxin Chen
JYJiaao Yu
Jiaao Yu
Xiu-Hang ZhangXiu-Hang Zhang
Xiu-Hang Zhang
Skin damage as a result of injury, be it acute or chronic, can adversely impact the quality of life of affected individuals, with serious wounds being life-threatening in certain cases, leading to a high clinical demand for effective wound dressing materials. Effective wound dressings are those which maintain moisture in the wound site, maintaining hemostasis while preventing the development of any infections, thereby allowing air and water to more effectively facilitate epithelization. At present the bioactivity of most wound dressings is relatively poor, with more effective dressings being very costly and difficult to produce, necessitating the development of novel wound healing materials. Recent research has highlighted the potential of electrospun fibrous membranes as a material for use in wound dressing design. Membranes designed using electrospinning technology have desirable features including a pore size that is readily tunable, as well as substantial air permeability and a high surface-to-volume ratio. These membranes also have a 3D structure that is similar to the structure of the extracellular matrix (ECM), which is essential for mediating effective cellular adhesion and proliferation. These advantageous properties make such electrospun fibers potentially ideal for use in wound dressings. Studies have further sought to functionalize these fibers so as to enhance their ability to promote wound healing via imbuing them with growth factors, antibacterial compounds, or other bioactive materials. Current ongoing efforts have to functionalize electrospun fibers offer great potential for efforts to regulate wound healing. Given their safety and relatively low cost, bioactive plant extracts have been the subject of particular interest in the context of wound healing. One such extract is bromelain, which is a crude extract isolated from the pineapple fruit that contains a number of therapeutically valuable proteolytic enzymes. Previous work has shown bromelain to be capable of mediating anti-inflammatory and anti-edematous properties in many contexts including sinusitis, thrombophlebitis, angina pectoris, bronchitis, surgical trauma, and pyelonephritis. Bromelain is also known to be capable of hydrolyzing devitalized tissues so as to enhance rates of wound healing. Efforts to maintain the stability of bromelain are essential for its therapeutic utilization, with previous groups having demonstrated that bromelain can be effectively incorporated into electrospun or other polymer matrices. For example, Bayat et al. were able to use a blending electrospinning process to generate chitosan nanofibers loaded with bromelain, while Korrapati et al. used coaxial electrospinning in order to incorporate bromelain into electrospun fibers. In addition to direct incorporation, bromelain can also be immobilized directly onto the surface of electrospun fibers, allowing for more direct interaction between bromelain and wound tissue. Unfortunately, electrospun fibers tend to interact poorly with enzymes, resulting in relatively poor enzymatic activity and stability. Therefore there is a need to develop better techniques for immobilizing bromelain onto electrospun fibers. Previous studies have highlighted the potential of mussel-inspired polydopamine (PDA), which is produced via oxidatively polymerizing dopamine, as a substrate with the potential for utilization in the development of advanced biomaterials. PDA is readily deposited onto a wide range of surfaces without the need of expensive or complex instruments and procedures in order to achieve this deposition. Importantly, PDA is highly versatile owing to the abundance of available functional groups, allowing it to be developed into a platform well-suited to use in myriad applications. PDA has been shown to ameliorate enzymatic immobilization via both Schiff base reactions and Michael-type addition. However, at present there are no reports regarding the potential for PDA to facilitate bromelain immobilization. In the present report we describe the successful use of PDA to mediate bromelain immobilization on electrospun fibers, with the resultant fibers being effective when used for dressing wounds. The synthetic polymer poly(e-caprolactone) (PCL), which exhibits good biocompatibility, was selected for use as a matrix that was used to generate a fibrous membrane onto which bromelain could be immobilized. The FDA has approved the biomedical use of PCL, and it has previously been shown to exhibit both a high degree of mechanical stability while also remaining biodegradable. In this report, we first immobilized bromelain onto electrospun PCL fibers via use of PDA and then explored the physical and chemical properties of the resultant membranes and of the bromelain deposited thereupon. We additionally assessed the utility of these membranes as mediators of cellular adhesion, cell proliferation, and antibacterial activity in vitro, and as drivers of enhanced wound healing in vivo. Together our findings highlight these bromelain-immobilized electrospun PCL fiber membranes as having great promise for use in wound healing applications. PCL fiber were prepared via electrospinning, then bromelain-immobilized PCL fiber were generated. The surface morphology of fibers was obtained by scanning electron microscopy. Swelling test, water vapor transmission rates (WVTR), in vitro bromelain release and loading, enzyme activity and stability were tested to demonstrate the fiber scaffold characteristic. The prepared composite scaffolds had satisfactory antibacterial activity via Kirby–Bauer (K-B) disc method. The cell studies were performed to reveal that the scaffolds were biocompatible and safe for cell attachment. Histological and immunohistochemical examinations were performed in rats. In Vivo wound healing model were chosen to verify the PCL functionalization using PDA and bromelain can accelerate the wound healing process. We found that bromelain activity could be better stabilized when via its immobilization on electrospun fibers. The resultant BrPDA-PCL fibers exhibited promising properties including optimal mechanical stability, wettability, and rates of water vapor transmission. In addition, these BrPDA-PCL fibers were biocompatible, allowing for effective cellular adhesion and proliferation. The results of zone of inhibition testing further confirmed that these fibers achieved effective antibacterial activity against Escherichia coli and Staphylococcus aureus. When used in vivo, as compared with PCL fibers or control animals the BrPDA-PCL fibers enhanced wound healing rates while reducing associated inflammation. Herein we found that using PDA to immobilize bromelain onto electrospun PCL fibers resulted in the production of membranes that were highly effective wound dressings. Bromelain activity was markedly stabilized via the immobilization process, and the resultant BrPDA-PCL fibers were capable of supporting both cellular adhesion and proliferation. Given the observed synergy between PDA and bromelain, these BrPDA-PCL fibers also exhibited antibacterial activity. When utilized in a rat model of wound healing, inflammation was reduced and healing rates were improved in rats treated using BrPDA-PCL fibers relative to untreated controls. We therefore propose that future studies further examine the value of bromelain-immobilized electrospun PCL fibers as a means of enhancing epithelial regeneration. The electrospun BrPDA-PCL fibers were capable of loading and delivering drugs, and could be potentially used as novel antibacterial burn wound dressings. These scaffolds have promising potential applications in infection control at the early phase of burn injury and accelerate wound healing process.